Review




Structured Review

Merck & Co ikk inhibitor xii
Ikk Inhibitor Xii, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ikk+inhibitor+xii/10__3390_slash_ijms27073232-261-81-86?v=Merck+%26+Co
Average 86 stars, based on 1 article reviews
ikk inhibitor xii - by Bioz Stars, 2026-07
86/100 stars

Images



Similar Products

93
MedChemExpress ikk inhibitor xii
Ikk Inhibitor Xii, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ikk+inhibitor+xii/10__3390_slash_ijms27073232-261-81-106?v=MedChemExpress
Average 93 stars, based on 1 article reviews
ikk inhibitor xii - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

86
Merck & Co ikk inhibitor xii
Ikk Inhibitor Xii, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ikk+inhibitor+xii/10__3390_slash_ijms27073232-261-81-86?v=Merck+%26+Co
Average 86 stars, based on 1 article reviews
ikk inhibitor xii - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

90
Merck KGaA ikk inhibitor xii
Ikk Inhibitor Xii, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ikk+inhibitor+xii/pm36268590-480-53-56?v=Merck+KGaA
Average 90 stars, based on 1 article reviews
ikk inhibitor xii - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Millipore ikk inhibitor xii (cat# 401491)
PAUF activates the MyD88-dependent, not the TRIF-dependent, TLR4 downstream pathway. ( A ) Panc-1_Mock and Panc-1_TLR4 OE cells were treated with rPAUF (0.1 μg/mL) for 0, 10, 30, and 60 min. Collected proteins were immunoprecipitated with MyD88 antibody (α-MyD88) using protein A agarose beads. Immunocomplexes were determined by Western blot against MyD88 and TLR4. ( B ) Panc-1_Mock and Panc-1_TLR4 OE cells were treated with rPAUF (0.1 μg/mL) for 0, 60, and 120 min. Collected proteins were immunoprecipitated with TRIF antibody (α-TRIF) using protein A agarose beads. Immunocomplexes were determined by Western blot against TRIF and TLR4. ( C ) Western blot showed that Panc-1_trans TLR4 OE cells were successfully engineered to transiently overexpress TLR4, compared to the control, Panc-1_trans Ctrl cells. ( D ) Panc-1_trans Ctrl and Panc-1_trans TLR4 OE cells were pretreated with or without <t>IKK</t> inhibitor <t>XII</t> (5 μM) for 4 h before rPAUF (0.1 μg/mL) or PBS treatment. After overnight culture, cells were collected for dual-luciferase activity assay. Data are represented as a mean ± SD from triplicates (**** p < 0.0001 were obtained from two-way ANOVA and post-hoc multiple comparisons with Bonferroni correction). ( E ) Panc-1_Mock and Panc-1_TLR4 OE cells were treated with rPAUF (0.1 μg/mL) for 0, 10, 30, 60, 120, and 240 min, and activation of TRIF-dependent TLR4 downstream molecules (p-TBK1 and p-IRF3) was estimated using Western blot.
Ikk Inhibitor Xii (Cat# 401491), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ikk+inhibitor+xii/pmc09570212-184-48-56?v=Millipore
Average 90 stars, based on 1 article reviews
ikk inhibitor xii (cat# 401491) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Millipore ikk inhibitor xii
PAUF activates the MyD88-dependent, not the TRIF-dependent, TLR4 downstream pathway. ( A ) Panc-1_Mock and Panc-1_TLR4 OE cells were treated with rPAUF (0.1 μg/mL) for 0, 10, 30, and 60 min. Collected proteins were immunoprecipitated with MyD88 antibody (α-MyD88) using protein A agarose beads. Immunocomplexes were determined by Western blot against MyD88 and TLR4. ( B ) Panc-1_Mock and Panc-1_TLR4 OE cells were treated with rPAUF (0.1 μg/mL) for 0, 60, and 120 min. Collected proteins were immunoprecipitated with TRIF antibody (α-TRIF) using protein A agarose beads. Immunocomplexes were determined by Western blot against TRIF and TLR4. ( C ) Western blot showed that Panc-1_trans TLR4 OE cells were successfully engineered to transiently overexpress TLR4, compared to the control, Panc-1_trans Ctrl cells. ( D ) Panc-1_trans Ctrl and Panc-1_trans TLR4 OE cells were pretreated with or without <t>IKK</t> inhibitor <t>XII</t> (5 μM) for 4 h before rPAUF (0.1 μg/mL) or PBS treatment. After overnight culture, cells were collected for dual-luciferase activity assay. Data are represented as a mean ± SD from triplicates (**** p < 0.0001 were obtained from two-way ANOVA and post-hoc multiple comparisons with Bonferroni correction). ( E ) Panc-1_Mock and Panc-1_TLR4 OE cells were treated with rPAUF (0.1 μg/mL) for 0, 10, 30, 60, 120, and 240 min, and activation of TRIF-dependent TLR4 downstream molecules (p-TBK1 and p-IRF3) was estimated using Western blot.
Ikk Inhibitor Xii, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ikk+inhibitor+xii/pm33901898-208-21-20?v=Millipore
Average 90 stars, based on 1 article reviews
ikk inhibitor xii - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


PAUF activates the MyD88-dependent, not the TRIF-dependent, TLR4 downstream pathway. ( A ) Panc-1_Mock and Panc-1_TLR4 OE cells were treated with rPAUF (0.1 μg/mL) for 0, 10, 30, and 60 min. Collected proteins were immunoprecipitated with MyD88 antibody (α-MyD88) using protein A agarose beads. Immunocomplexes were determined by Western blot against MyD88 and TLR4. ( B ) Panc-1_Mock and Panc-1_TLR4 OE cells were treated with rPAUF (0.1 μg/mL) for 0, 60, and 120 min. Collected proteins were immunoprecipitated with TRIF antibody (α-TRIF) using protein A agarose beads. Immunocomplexes were determined by Western blot against TRIF and TLR4. ( C ) Western blot showed that Panc-1_trans TLR4 OE cells were successfully engineered to transiently overexpress TLR4, compared to the control, Panc-1_trans Ctrl cells. ( D ) Panc-1_trans Ctrl and Panc-1_trans TLR4 OE cells were pretreated with or without IKK inhibitor XII (5 μM) for 4 h before rPAUF (0.1 μg/mL) or PBS treatment. After overnight culture, cells were collected for dual-luciferase activity assay. Data are represented as a mean ± SD from triplicates (**** p < 0.0001 were obtained from two-way ANOVA and post-hoc multiple comparisons with Bonferroni correction). ( E ) Panc-1_Mock and Panc-1_TLR4 OE cells were treated with rPAUF (0.1 μg/mL) for 0, 10, 30, 60, 120, and 240 min, and activation of TRIF-dependent TLR4 downstream molecules (p-TBK1 and p-IRF3) was estimated using Western blot.

Journal: International Journal of Molecular Sciences

Article Title: PAUF Induces Migration of Human Pancreatic Cancer Cells Exclusively via the TLR4/MyD88/NF-κB Signaling Pathway

doi: 10.3390/ijms231911414

Figure Lengend Snippet: PAUF activates the MyD88-dependent, not the TRIF-dependent, TLR4 downstream pathway. ( A ) Panc-1_Mock and Panc-1_TLR4 OE cells were treated with rPAUF (0.1 μg/mL) for 0, 10, 30, and 60 min. Collected proteins were immunoprecipitated with MyD88 antibody (α-MyD88) using protein A agarose beads. Immunocomplexes were determined by Western blot against MyD88 and TLR4. ( B ) Panc-1_Mock and Panc-1_TLR4 OE cells were treated with rPAUF (0.1 μg/mL) for 0, 60, and 120 min. Collected proteins were immunoprecipitated with TRIF antibody (α-TRIF) using protein A agarose beads. Immunocomplexes were determined by Western blot against TRIF and TLR4. ( C ) Western blot showed that Panc-1_trans TLR4 OE cells were successfully engineered to transiently overexpress TLR4, compared to the control, Panc-1_trans Ctrl cells. ( D ) Panc-1_trans Ctrl and Panc-1_trans TLR4 OE cells were pretreated with or without IKK inhibitor XII (5 μM) for 4 h before rPAUF (0.1 μg/mL) or PBS treatment. After overnight culture, cells were collected for dual-luciferase activity assay. Data are represented as a mean ± SD from triplicates (**** p < 0.0001 were obtained from two-way ANOVA and post-hoc multiple comparisons with Bonferroni correction). ( E ) Panc-1_Mock and Panc-1_TLR4 OE cells were treated with rPAUF (0.1 μg/mL) for 0, 10, 30, 60, 120, and 240 min, and activation of TRIF-dependent TLR4 downstream molecules (p-TBK1 and p-IRF3) was estimated using Western blot.

Article Snippet: For luciferase reporter assays, the pGL4.32[luc2P/NF-κB-RE/Hygro] and pRL-TK vectors, Lipofectamine 2000 transfection reagent (cat# 11668019) was purchased from Invitrogen, and Dual-Luciferase Reporter Assay System (cat# E1960) were purchased from Promega (Madison, WI, USA), the pDUO-mcs vector (cat# pduo-mcs) was purchased from InvivoGen (San Diego, CA, USA), and the IKK inhibitor XII (cat# 401491) were purchased from Sigma-Aldrich.

Techniques: Immunoprecipitation, Western Blot, Luciferase, Activity Assay, Activation Assay